Global Hereditary Angioedema Market By Drug Class (C-1 Esterase Inhibitors, Bradykynin Receptor Antagonist, Kallikrein Inhibitors and Others), By Treatment Approach (Acute Treatment, Prophylactic (Preventive) Treatment and On-demand (Symptom Relief) Treatment), By Route of Administration (Intravenous, Subcutaneous and Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Table of Contents

• 1. Executive Summary
  • 1.1. Definition
  • 1.2. Market Snapshot
  • 1.3. Market Overview
  • 1.4. Segment Overview
  • 1.5. Regional Overview
  • 1.6. Competitive Landscape
  • 1.7. Taxonomy
• 2. Global Market Overview
  • 2.1. Global Market Insights and Industry Overview
  • 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.1.1. Increasing Awareness and Diagnosis
  • 2.2.2. Restraints
  • 2.2.2.1. High Treatment Costs
  • 2.2.3. Opportunities
  • 2.2.3.1. Pipeline Development
  • 2.2.4. Key Hereditary Angioedema Market Trends
  • 2.3. Regulatory Framework
  • 2.4. Opportunity Map Analysis
  • 2.5. Opportunity Orbits
  • 2.6. PESTLE Analysis
  • 2.7. PORTER’S Five Force Analysis
  • 2.8. Drivers & Restraints Impact Analysis
  • 2.9. Value Chain Analysis
  • 2.9.1. List of Raw Materials Suppliers
  • 2.9.2. List of Hereditary Angioedema Manufacturers
  • 2.9.3. List of Dealer/Distributors
  • 2.10. Regional Market Share and BPS Analysis
  • 2.11. Impact of Macro-economic Factors/Geopolitical Factors
• 3. Global Hereditary Angioedema Market Analysis and Forecast, By Segment, 2019-2033
  • 3.1. Key Findings
  • 3.2. Global Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
  • 3.3. Global Hereditary Angioedema Market Attractiveness Analysis, By Drug Class
  • 3.3.1. C-1 Esterase Inhibitors
  • 3.3.1.1. Insights
  • 3.3.1.2. Key Takeaways
  • 3.3.2. Bradykynin Receptor Antagonist
  • 3.3.2.1. Insights
  • 3.3.2.2. Key Takeaways
  • 3.3.3. Kallikrein Inhibitors
  • 3.3.3.1. Insights
  • 3.3.3.2. Key Takeaways
  • 3.3.4. Others
  • 3.3.4.1. Insights
  • 3.3.4.2. Key Takeaways
  • 3.4. Global Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Approach, 2019-2033
  • 3.5. Global Hereditary Angioedema Market Attractiveness Analysis, By Treatment Approach
  • 3.5.1. Acute Treatment
  • 3.5.1.1. Insights
  • 3.5.1.2. Key Takeaways
  • 3.5.2. Prophylactic (Preventive) Treatment
  • 3.5.2.1. Insights
  • 3.5.2.2. Key Takeaways
  • 3.5.3. On-demand (Symptom Relief) Treatment
  • 3.5.3.1. Insights
  • 3.5.3.2. Key Takeaways
  • 3.6. Global Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
  • 3.7. Global Hereditary Angioedema Market Attractiveness Analysis, By Route of Administration
  • 3.7.1. Intravenous
  • 3.7.1.1. Insights
  • 3.7.1.2. Key Takeaways
  • 3.7.2. Subcutaneous
  • 3.7.2.1. Insights
  • 3.7.2.2. Key Takeaways
  • 3.7.3. Oral
  • 3.7.3.1. Insights
  • 3.7.3.2. Key Takeaways
  • 3.8. Global Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  • 3.9. Global Hereditary Angioedema Market Attractiveness Analysis, By Distribution Channel
  • 3.9.1. Hospital Pharmacies
  • 3.9.1.1. Insights
  • 3.9.1.2. Key Takeaways
  • 3.9.2. Retail Pharmacies
  • 3.9.2.1. Insights
  • 3.9.2.2. Key Takeaways
  • 3.9.3. Online Pharmacies
  • 3.9.3.1. Insights
  • 3.9.3.2. Key Takeaways
• 4. Global Hereditary Angioedema Market Analysis and Forecast, By Region, 2019-2033
  • 4.1. Key Findings
  • 4.2. Global Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2019-2033
  • 4.2.1. North America
  • 4.2.1.1. Regional Insights
  • 4.2.2. Europe
  • 4.2.2.1. Regional Insights
  • 4.2.3. Asia Pacific
  • 4.2.3.1. Regional Insights
  • 4.2.4. Latin America
  • 4.2.4.1. Regional Insights
  • 4.2.5. Middle East & Africa
  • 4.2.5.1. Regional Insights
  • 4.3. Global Hereditary Angioedema Market Attractiveness Analysis, By Region
• 5. North America Hereditary Angioedema Market Analysis and Forecast, 2019-2033
  • 5.1. Key Findings
  • 5.2. North America Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
  • 5.3. North America Hereditary Angioedema Market Attractiveness Analysis, By Drug Class
  • 5.4. North America Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Approach, 2019-2033
  • 5.5. North America Hereditary Angioedema Market Attractiveness Analysis, By Treatment Approach
  • 5.6. North America Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
  • 5.7. North America Hereditary Angioedema Market Attractiveness Analysis, By Route of Administration
  • 5.8. North America Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  • 5.9. North America Hereditary Angioedema Market Attractiveness Analysis, By Distribution Channel
  • 5.10. North America Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  • 5.11. North America Hereditary Angioedema Market Attractiveness Analysis, By Country
  • 5.11.1. The US
  • 5.11.2. Canada
• 6. Europe Hereditary Angioedema Market Analysis and Forecast, 2019-2033
  • 6.1. Key Findings
  • 6.2. Europe Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
  • 6.3. Europe Hereditary Angioedema Market Attractiveness Analysis, By Drug Class
  • 6.4. Europe Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Approach, 2019-2033
  • 6.5. Europe Hereditary Angioedema Market Attractiveness Analysis, By Treatment Approach
  • 6.6. Europe Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
  • 6.7. Europe Hereditary Angioedema Market Attractiveness Analysis, By Route of Administration
  • 6.8. Europe Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  • 6.9. Europe Hereditary Angioedema Market Attractiveness Analysis, By Distribution Channel
  • 6.10. Europe Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  • 6.11. Europe Hereditary Angioedema Market Attractiveness Analysis, By Country
  • 6.11.1. Germany
  • 6.11.2. The UK
  • 6.11.3. France
  • 6.11.4. Spain
  • 6.11.5. Italy
  • 6.11.6. Russia
  • 6.11.7. Netherland
  • 6.11.8. Rest of Europe
• 7. Asia Pacific Hereditary Angioedema Market Analysis and Forecast, 2019-2033
  • 7.1. Key Findings
  • 7.2. Asia Pacific Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
  • 7.3. Asia Pacific Hereditary Angioedema Market Attractiveness Analysis, By Drug Class
  • 7.4. Asia Pacific Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Approach, 2019-2033
  • 7.5. Asia Pacific Hereditary Angioedema Market Attractiveness Analysis, By Treatment Approach
  • 7.6. Asia Pacific Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
  • 7.7. Asia Pacific Hereditary Angioedema Market Attractiveness Analysis, By Route of Administration
  • 7.8. Asia Pacific Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  • 7.9. Asia Pacific Hereditary Angioedema Market Attractiveness Analysis, By Distribution Channel
  • 7.10. Asia Pacific Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  • 7.11. Asia Pacific Hereditary Angioedema Market Attractiveness Analysis, By Country
  • 7.11.1. China
  • 7.11.2. Japan
  • 7.11.3. South Korea
  • 7.11.4. India
  • 7.11.5. Australia
  • 7.11.6. New Zealand
  • 7.11.7. Singapore
  • 7.11.8. Thailand
  • 7.11.9. Vietnam
  • 7.11.10. Rest of Asia Pacific
• 8. Latin America Hereditary Angioedema Market Analysis and Forecast, 2019-2033
  • 8.1. Key Findings
  • 8.2. Latin America Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
  • 8.3. Latin America Hereditary Angioedema Market Attractiveness Analysis, By Drug Class
  • 8.4. Latin America Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Approach, 2019-2033
  • 8.5. Latin America Hereditary Angioedema Market Attractiveness Analysis, By Treatment Approach
  • 8.6. Latin America Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
  • 8.7. Latin America Hereditary Angioedema Market Attractiveness Analysis, By Route of Administration
  • 8.8. Latin America Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  • 8.9. Latin America Hereditary Angioedema Market Attractiveness Analysis, By Distribution Channel
  • 8.10. Latin America Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  • 8.11. Latin America Hereditary Angioedema Market Attractiveness Analysis, By Country
  • 8.11.1. Brazil
  • 8.11.2. Mexico
  • 8.11.3. Rest of Latin America
• 9. Middle East & Africa Hereditary Angioedema Market Analysis and Forecast, 2019-2033
  • 9.1. Key Findings
  • 9.2. Middle East & Africa Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
  • 9.3. Middle East & Africa Hereditary Angioedema Market Attractiveness Analysis, By Drug Class
  • 9.4. Middle East & Africa Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Treatment Approach, 2019-2033
  • 9.5. Middle East & Africa Hereditary Angioedema Market Attractiveness Analysis, By Treatment Approach
  • 9.6. Middle East & Africa Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
  • 9.7. Middle East & Africa Hereditary Angioedema Market Attractiveness Analysis, By Route of Administration
  • 9.8. Middle East & Africa Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
  • 9.9. Middle East & Africa Hereditary Angioedema Market Attractiveness Analysis, By Distribution Channel
  • 9.10. Middle East & Africa Hereditary Angioedema Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  • 9.11. Middle East & Africa Hereditary Angioedema Market Attractiveness Analysis, By Country
  • 9.11.1. South Africa
  • 9.11.2. Saudi Arabia
  • 9.11.3. UAE
  • 9.11.4. Rest of Middle East & Africa
• 10. Competitive Landscape & Company Profiles
  • 10.1. Market Competition Scenario Analysis, By Company
  • 10.1.1. Key Takeaways
  • 10.2. Overview of Major Market Players
  • 10.3. Competitor Landscape
  • 10.4. Strategic Mapping
  • 10.5. Company Life Cycle Analysis
  • 10.6. Company Market Share Analysis
  • 10.7. Company Profiles
  • 10.7.1. BioCryst Pharmaceuticals, Inc.
  • 10.7.1.1. Company Details
  • 10.7.1.2. Business Overview
  • 10.7.1.3. Product Portfolio
  • 10.7.1.4. Financial Insights
  • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
  • 10.7.1.6. SWOT Analysis
  • 10.7.1.7. Geographic Footprint
  • 10.7.2. Ionis Pharmaceuticals
  • 10.7.2.1. Company Details
  • 10.7.2.2. Business Overview
  • 10.7.2.3. Product Portfolio
  • 10.7.2.4. Financial Insights
  • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
  • 10.7.2.6. SWOT Analysis
  • 10.7.2.7. Geographic Footprint
  • 10.7.3. CSL
  • 10.7.3.1. Company Details
  • 10.7.3.2. Business Overview
  • 10.7.3.3. Product Portfolio
  • 10.7.3.4. Financial Insights
  • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
  • 10.7.3.6. SWOT Analysis
  • 10.7.3.7. Geographic Footprint
  • 10.7.4. Attune Pharmaceuticals
  • 10.7.4.1. Company Details
  • 10.7.4.2. Business Overview
  • 10.7.4.3. Product Portfolio
  • 10.7.4.4. Financial Insights
  • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
  • 10.7.4.6. SWOT Analysis
  • 10.7.4.7. Geographic Footprint
  • 10.7.5. Adverum Biotechnologies, Inc.
  • 10.7.5.1. Company Details
  • 10.7.5.2. Business Overview
  • 10.7.5.3. Product Portfolio
  • 10.7.5.4. Financial Insights
  • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
  • 10.7.5.6. SWOT Analysis
  • 10.7.5.7. Geographic Footprint
  • 10.7.6. KalVista Pharmaceuticals, Inc.
  • 10.7.6.1. Company Details
  • 10.7.6.2. Business Overview
  • 10.7.6.3. Product Portfolio
  • 10.7.6.4. Financial Insights
  • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
  • 10.7.6.6. SWOT Analysis
  • 10.7.6.7. Geographic Footprint
  • 10.7.7. Takeda Pharmaceutical Company Limited
  • 10.7.7.1. Company Details
  • 10.7.7.2. Business Overview
  • 10.7.7.3. Product Portfolio
  • 10.7.7.4. Financial Insights
  • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
  • 10.7.7.6. SWOT Analysis
  • 10.7.7.7. Geographic Footprint
  • 10.7.8. Pharming
  • 10.7.8.1. Company Details
  • 10.7.8.2. Business Overview
  • 10.7.8.3. Product Portfolio
  • 10.7.8.4. Financial Insights
  • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
  • 10.7.8.6. SWOT Analysis
  • 10.7.8.7. Geographic Footprint
  • 10.7.9. Shire plc.
  • 10.7.9.1. Company Details
  • 10.7.9.2. Business Overview
  • 10.7.9.3. Product Portfolio
  • 10.7.9.4. Financial Insights
  • 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
  • 10.7.9.6. SWOT Analysis
  • 10.7.9.7. Geographic Footprint
  • 10.7.10. Arrowhead Pharmaceuticals, Inc.
  • 10.7.10.1. Company Details
  • 10.7.10.2. Business Overview
  • 10.7.10.3. Product Portfolio
  • 10.7.10.4. Financial Insights
  • 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
  • 10.7.10.6. SWOT Analysis
  • 10.7.10.7. Geographic Footprint
  • 10.7.11. Adverum
  • 10.7.11.1. Company Details
  • 10.7.11.2. Business Overview
  • 10.7.11.3. Product Portfolio
  • 10.7.11.4. Financial Insights
  • 10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
  • 10.7.11.6. SWOT Analysis
  • 10.7.11.7. Geographic Footprint
• 11. Methodology and Data Source
  • 11.1. Methodology/Research Approach
  • 11.2. Market Size Estimation
  • 11.3. Market Breakdown and Data Triangulation
  • 11.4. Data Source
  • 11.5. Secondary Sources
  • 11.6. Primary Sources
  • 11.7. Appendix
  • 11.8. Disclaimer

List of Tables

• Table 1. Global Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 2. Global Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 3. Global Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 4. Global Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 5. Global Hereditary Angioedema Market Value (US$ Mn), By Region, 2019-2033
• Table 6. North America Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 7. North America Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 8. North America Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 9. North America Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 10. North America Hereditary Angioedema Market Value (US$ Mn), By Country, 2019-2033
• Table 11. The US Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 12. The US Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 13. The US Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 14. The US Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 15. Canada Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 16. Canada Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 17. Canada Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 18. Canada Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 19. Europe Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 20. Europe Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 21. Europe Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 22. Europe Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 23. Europe Hereditary Angioedema Market Value (US$ Mn), By Country, 2019-2033
• Table 24. Germany Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 25. Germany Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 26. Germany Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 27. Germany Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 28. The UK Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 29. The UK Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 30. The UK Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 31. The UK Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 32. France Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 33. France Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 34. France Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 35. France Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 36. Spain Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 37. Spain Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 38. Spain Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 39. Spain Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 40. Italy Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 41. Italy Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 42. Italy Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 43. Italy Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 44. Russia Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 45. Russia Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 46. Russia Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 47. Russia Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 48. Netherland Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 49. Netherland Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 50. Netherland Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 51. Netherland Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 52. Rest of Europe Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 53. Rest of Europe Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 54. Rest of Europe Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 55. Rest of Europe Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 56. Asia Pacific Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 57. Asia Pacific Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 58. Asia Pacific Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 59. Asia Pacific Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 60. Asia Pacific Hereditary Angioedema Market Value (US$ Mn), By Country, 2019-2033
• Table 61. China Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 62. China Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 63. China Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 64. China Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 65. India Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 66. India Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 67. India Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 68. India Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 69. Japan Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 70. Japan Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 71. Japan Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 72. Japan Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 73. South Korea Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 74. South Korea Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 75. South Korea Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 76. South Korea Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 77. Australia Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 78. Australia Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 79. Australia Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 80. Australia Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 81. New Zealand Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 82. New Zealand Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 83. New Zealand Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 84. New Zealand Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 85. Singapore Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 86. Singapore Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 87. Singapore Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 88. Singapore Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 89. Thailand Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 90. Thailand Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 91. Thailand Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 92. Thailand Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 93. Vietnam Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 94. Vietnam Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 95. Vietnam Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 96. Vietnam Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 97. Rest of Asia Pacific Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 98. Rest of Asia Pacific Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 99. Rest of Asia Pacific Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 100. Rest of Asia Pacific Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 101. Latin America Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 102. Latin America Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 103. Latin America Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 104. Latin America Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 105. Latin America Hereditary Angioedema Market Value (US$ Mn), By Country, 2019-2033
• Table 106. Brazil Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 107. Brazil Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 108. Brazil Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 109. Brazil Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 110. Mexico Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 111. Mexico Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 112. Mexico Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 113. Mexico Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 114. Rest of Latin America Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 115. Rest of Latin America Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 116. Rest of Latin America Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 117. Rest of Latin America Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 118. Middle East & Africa Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 119. Middle East & Africa Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 120. Middle East & Africa Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 121. Middle East & Africa Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 122. Middle East & Africa Hereditary Angioedema Market Value (US$ Mn), By Country, 2019-2033
• Table 123. South Africa Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 124. South Africa Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 125. South Africa Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 126. South Africa Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 127. Saudi Arabia Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 128. Saudi Arabia Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 129. Saudi Arabia Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 130. Saudi Arabia Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 131. UAE Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 132. UAE Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 133. UAE Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 134. UAE Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033
• Table 135. Rest of Middle East & Africa Hereditary Angioedema Market Value (US$ Mn), By Drug Class, 2019-2033
• Table 136. Rest of Middle East & Africa Hereditary Angioedema Market Value (US$ Mn), By Treatment Approach, 2019-2033
• Table 137. Rest of Middle East & Africa Hereditary Angioedema Market Value (US$ Mn), By Route of Administration, 2019-2033
• Table 138. Rest of Middle East & Africa Hereditary Angioedema Market Value (US$ Mn), By Distribution Channel, 2019-2033

List of Figures

• Figure 1. Global Hereditary Angioedema Market Snapshot: Market Value (US$ Mn), 2019-2033
• Figure 2. Opportunity Map
• Figure 3. Opportunity Orbit
• Figure 4. Regional Market Share and BPS Analysis in Hereditary Angioedema Market
• Figure 5. Global Hereditary Angioedema Market Analysis, By Drug Class, 2019, 2023 and 2033
• Figure 6. Global Hereditary Angioedema Market Attractiveness Analysis, By Drug Class
• Figure 7. Global Hereditary Angioedema Market Analysis, By Treatment Approach, 2019, 2023 and 2033
• Figure 8. Global Hereditary Angioedema Market Attractiveness Analysis, By Treatment Approach
• Figure 9. Global Hereditary Angioedema Market Analysis, By Route of Administration, 2019, 2023 and 2033
• Figure 10. Global Hereditary Angioedema Market Attractiveness Analysis, By Route of Administration
• Figure 11. Global Hereditary Angioedema Market Analysis, By Distribution Channel, 2019, 2023 and 2033
• Figure 12. Global Hereditary Angioedema Market Attractiveness Analysis, By Distribution Channel
• Figure 13. Global Hereditary Angioedema Market Analysis, By Region, 2019, 2023 and 2033
• Figure 14. Global Hereditary Angioedema Market Attractiveness Analysis, By Region
• Figure 15. North America Hereditary Angioedema Market Analysis, By Drug Class, 2019, 2023 and 2033
• Figure 16. North America Hereditary Angioedema Market Attractiveness Analysis, By Drug Class
• Figure 17. North America Hereditary Angioedema Market (US$ Mn), by C-1 Esterase Inhibitors, 2019-2033
• Figure 18. North America Hereditary Angioedema Market (US$ Mn), by Bradykynin Receptor Antagonist, 2019-2033
• Figure 19. North America Hereditary Angioedema Market (US$ Mn), by Kallikrein Inhibitors, 2019-2033
• Figure 20. North America Hereditary Angioedema Market (US$ Mn), by Others, 2019-2033
• Figure 21. North America Hereditary Angioedema Market (US$ Mn), by Drug Class 5, 2019-2033
• Figure 22. North America Hereditary Angioedema Market (US$ Mn), by Drug Class 6, 2019-2033
• Figure 23. North America Hereditary Angioedema Market (US$ Mn), by Drug Class 7, 2019-2033
• Figure 24. North America Hereditary Angioedema Market (US$ Mn), by Drug Class 8, 2019-2033
• Figure 25. North America Hereditary Angioedema Market (US$ Mn), by Drug Class 9, 2019-2033
• Figure 26. North America Hereditary Angioedema Market (US$ Mn), by C-1 Esterase Inhibitors0, 2019-2033
• Figure 27. North America Hereditary Angioedema Market Analysis, By Treatment Approach, 2019, 2023 and 2033
• Figure 28. North America Hereditary Angioedema Market Attractiveness Analysis, By Treatment Approach
• Figure 29. North America Hereditary Angioedema Market (US$ Mn), by Acute Treatment, 2019-2033
• Figure 30. North America Hereditary Angioedema Market (US$ Mn), by Prophylactic (Preventive) Treatment, 2019-2033
• Figure 31. North America Hereditary Angioedema Market (US$ Mn), by On-demand (Symptom Relief) Treatment, 2019-2033
• Figure 32. North America Hereditary Angioedema Market (US$ Mn), by Treatment Approach 4, 2019-2033
• Figure 33. North America Hereditary Angioedema Market (US$ Mn), by Treatment Approach 5, 2019-2033
• Figure 34. North America Hereditary Angioedema Market (US$ Mn), by Treatment Approach 6, 2019-2033
• Figure 35. North America Hereditary Angioedema Market (US$ Mn), by Treatment Approach 7, 2019-2033
• Figure 36. North America Hereditary Angioedema Market (US$ Mn), by Treatment Approach 8, 2019-2033
• Figure 37. North America Hereditary Angioedema Market (US$ Mn), by Treatment Approach 9, 2019-2033
• Figure 38. North America Hereditary Angioedema Market (US$ Mn), by Acute Treatment0, 2019-2033
• Figure 39. North America Hereditary Angioedema Market Analysis, By Route of Administration, 2019, 2023 and 2033
• Figure 40. North America Hereditary Angioedema Market Attractiveness Analysis, By Route of Administration
• Figure 41. North America Hereditary Angioedema Market (US$ Mn), by Intravenous, 2019-2033
• Figure 42. North America Hereditary Angioedema Market (US$ Mn), by Subcutaneous, 2019-2033
• Figure 43. North America Hereditary Angioedema Market (US$ Mn), by Oral, 2019-2033
• Figure 44. North America Hereditary Angioedema Market (US$ Mn), by Route of Administration 4, 2019-2033
• Figure 45. North America Hereditary Angioedema Market (US$ Mn), by Route of Administration 5, 2019-2033
• Figure 46. North America Hereditary Angioedema Market (US$ Mn), by Route of Administration 6, 2019-2033
• Figure 47. North America Hereditary Angioedema Market (US$ Mn), by Route of Administration 7, 2019-2033
• Figure 48. North America Hereditary Angioedema Market (US$ Mn), by Route of Administration 8, 2019-2033
• Figure 49. North America Hereditary Angioedema Market (US$ Mn), by Route of Administration 9, 2019-2033
• Figure 50. North America Hereditary Angioedema Market (US$ Mn), by Intravenous0, 2019-2033
• Figure 51. North America Hereditary Angioedema Market Analysis, By Distribution Channel, 2019, 2023 and 2033
• Figure 52. North America Hereditary Angioedema Market Attractiveness Analysis, By Distribution Channel
• Figure 53. North America Hereditary Angioedema Market (US$ Mn), by Hospital Pharmacies, 2019-2033
• Figure 54. North America Hereditary Angioedema Market (US$ Mn), by Retail Pharmacies, 2019-2033
• Figure 55. North America Hereditary Angioedema Market (US$ Mn), by Online Pharmacies, 2019-2033
• Figure 56. North America Hereditary Angioedema Market (US$ Mn), by Distribution Channel 4, 2019-2033
• Figure 57. North America Hereditary Angioedema Market (US$ Mn), by Distribution Channel 5, 2019-2033
• Figure 58. North America Hereditary Angioedema Market (US$ Mn), by Distribution Channel 6, 2019-2033
• Figure 59. North America Hereditary Angioedema Market (US$ Mn), by Distribution Channel 7, 2019-2033
• Figure 60. North America Hereditary Angioedema Market (US$ Mn), by Distribution Channel 8, 2019-2033
• Figure 61. North America Hereditary Angioedema Market (US$ Mn), by Distribution Channel 9, 2019-2033
• Figure 62. North America Hereditary Angioedema Market (US$ Mn), by Hospital Pharmacies0, 2019-2033
• Figure 63. North America Hereditary Angioedema Market Analysis, By Country, 2019, 2023 and 2033
• Figure 64. North America Hereditary Angioedema Market Attractiveness Analysis, By Country
• Figure 65. Europe Hereditary Angioedema Market Analysis, By Drug Class, 2019, 2023 and 2033
• Figure 66. Europe Hereditary Angioedema Market Attractiveness Analysis, By Drug Class
• Figure 67. Europe Hereditary Angioedema Market (US$ Mn), by C-1 Esterase Inhibitors, 2019-2033
• Figure 68. Europe Hereditary Angioedema Market (US$ Mn), by Bradykynin Receptor Antagonist, 2019-2033
• Figure 69. Europe Hereditary Angioedema Market (US$ Mn), by Kallikrein Inhibitors, 2019-2033
• Figure 70. Europe Hereditary Angioedema Market (US$ Mn), by Others, 2019-2033
• Figure 71. Europe Hereditary Angioedema Market (US$ Mn), by Drug Class 5, 2019-2033
• Figure 72. Europe Hereditary Angioedema Market (US$ Mn), by Drug Class 6, 2019-2033
• Figure 73. Europe Hereditary Angioedema Market (US$ Mn), by Drug Class 7, 2019-2033
• Figure 74. Europe Hereditary Angioedema Market (US$ Mn), by Drug Class 8, 2019-2033
• Figure 75. Europe Hereditary Angioedema Market (US$ Mn), by Drug Class 9, 2019-2033
• Figure 76. Europe Hereditary Angioedema Market (US$ Mn), by C-1 Esterase Inhibitors0, 2019-2033
• Figure 77. Europe Hereditary Angioedema Market Analysis, By Treatment Approach, 2019, 2023 and 2033
• Figure 78. Europe Hereditary Angioedema Market Attractiveness Analysis, By Treatment Approach
• Figure 79. Europe Hereditary Angioedema Market (US$ Mn), by Acute Treatment, 2019-2033
• Figure 80. Europe Hereditary Angioedema Market (US$ Mn), by Prophylactic (Preventive) Treatment, 2019-2033
• Figure 81. Europe Hereditary Angioedema Market (US$ Mn), by On-demand (Symptom Relief) Treatment, 2019-2033
• Figure 82. Europe Hereditary Angioedema Market (US$ Mn), by Treatment Approach 4, 2019-2033
• Figure 83. Europe Hereditary Angioedema Market (US$ Mn), by Treatment Approach 5, 2019-2033
• Figure 84. Europe Hereditary Angioedema Market (US$ Mn), by Treatment Approach 6, 2019-2033
• Figure 85. Europe Hereditary Angioedema Market (US$ Mn), by Treatment Approach 7, 2019-2033
• Figure 86. Europe Hereditary Angioedema Market (US$ Mn), by Treatment Approach 8, 2019-2033
• Figure 87. Europe Hereditary Angioedema Market (US$ Mn), by Treatment Approach 9, 2019-2033
• Figure 88. Europe Hereditary Angioedema Market (US$ Mn), by Acute Treatment0, 2019-2033
• Figure 89. Europe Hereditary Angioedema Market Analysis, By Route of Administration, 2019, 2023 and 2033
• Figure 90. Europe Hereditary Angioedema Market Attractiveness Analysis, By Route of Administration
• Figure 91. Europe Hereditary Angioedema Market (US$ Mn), by Intravenous, 2019-2033
• Figure 92. Europe Hereditary Angioedema Market (US$ Mn), by Subcutaneous, 2019-2033
• Figure 93. Europe Hereditary Angioedema Market (US$ Mn), by Oral, 2019-2033
• Figure 94. Europe Hereditary Angioedema Market (US$ Mn), by Route of Administration 4, 2019-2033
• Figure 95. Europe Hereditary Angioedema Market (US$ Mn), by Route of Administration 5, 2019-2033
• Figure 96. Europe Hereditary Angioedema Market (US$ Mn), by Route of Administration 6, 2019-2033
• Figure 97. Europe Hereditary Angioedema Market (US$ Mn), by Route of Administration 7, 2019-2033
• Figure 98. Europe Hereditary Angioedema Market (US$ Mn), by Route of Administration 8, 2019-2033
• Figure 99. Europe Hereditary Angioedema Market (US$ Mn), by Route of Administration 9, 2019-2033
• Figure 100. Europe Hereditary Angioedema Market (US$ Mn), by Intravenous0, 2019-2033
• Figure 101. Europe Hereditary Angioedema Market Analysis, By Distribution Channel, 2019, 2023 and 2033
• Figure 102. Europe Hereditary Angioedema Market Attractiveness Analysis, By Distribution Channel
• Figure 103. Europe Hereditary Angioedema Market (US$ Mn), by Hospital Pharmacies, 2019-2033
• Figure 104. Europe Hereditary Angioedema Market (US$ Mn), by Retail Pharmacies, 2019-2033
• Figure 105. Europe Hereditary Angioedema Market (US$ Mn), by Online Pharmacies, 2019-2033
• Figure 106. Europe Hereditary Angioedema Market (US$ Mn), by Distribution Channel 4, 2019-2033
• Figure 107. Europe Hereditary Angioedema Market (US$ Mn), by Distribution Channel 5, 2019-2033
• Figure 108. Europe Hereditary Angioedema Market (US$ Mn), by Distribution Channel 6, 2019-2033
• Figure 109. Europe Hereditary Angioedema Market (US$ Mn), by Distribution Channel 7, 2019-2033
• Figure 110. Europe Hereditary Angioedema Market (US$ Mn), by Distribution Channel 8, 2019-2033
• Figure 111. Europe Hereditary Angioedema Market (US$ Mn), by Distribution Channel 9, 2019-2033
• Figure 112. Europe Hereditary Angioedema Market (US$ Mn), by Hospital Pharmacies0, 2019-2033
• Figure 113. Europe Hereditary Angioedema Market Analysis, By Country, 2019, 2023 and 2033
• Figure 114. Europe Hereditary Angioedema Market Attractiveness Analysis, By Country
• Figure 115. Asia Pacific Hereditary Angioedema Market Analysis, By Drug Class, 2019, 2023 and 2033
• Figure 116. Asia Pacific Hereditary Angioedema Market Attractiveness Analysis, By Drug Class
• Figure 117. Asia Pacific Hereditary Angioedema Market (US$ Mn), by C-1 Esterase Inhibitors, 2019-2033
• Figure 118. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Bradykynin Receptor Antagonist, 2019-2033
• Figure 119. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Kallikrein Inhibitors, 2019-2033
• Figure 120. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Others, 2019-2033
• Figure 121. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Drug Class 5, 2019-2033
• Figure 122. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Drug Class 6, 2019-2033
• Figure 123. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Drug Class 7, 2019-2033
• Figure 124. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Drug Class 8, 2019-2033
• Figure 125. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Drug Class 9, 2019-2033
• Figure 126. Asia Pacific Hereditary Angioedema Market (US$ Mn), by C-1 Esterase Inhibitors0, 2019-2033
• Figure 127. Asia Pacific Hereditary Angioedema Market Analysis, By Treatment Approach, 2019, 2023 and 2033
• Figure 128. Asia Pacific Hereditary Angioedema Market Attractiveness Analysis, By Treatment Approach
• Figure 129. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Acute Treatment, 2019-2033
• Figure 130. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Prophylactic (Preventive) Treatment, 2019-2033
• Figure 131. Asia Pacific Hereditary Angioedema Market (US$ Mn), by On-demand (Symptom Relief) Treatment, 2019-2033
• Figure 132. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Treatment Approach 4, 2019-2033
• Figure 133. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Treatment Approach 5, 2019-2033
• Figure 134. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Treatment Approach 6, 2019-2033
• Figure 135. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Treatment Approach 7, 2019-2033
• Figure 136. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Treatment Approach 8, 2019-2033
• Figure 137. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Treatment Approach 9, 2019-2033
• Figure 138. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Acute Treatment0, 2019-2033
• Figure 139. Asia Pacific Hereditary Angioedema Market Analysis, By Route of Administration, 2019, 2023 and 2033
• Figure 140. Asia Pacific Hereditary Angioedema Market Attractiveness Analysis, By Route of Administration
• Figure 141. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Intravenous, 2019-2033
• Figure 142. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Subcutaneous, 2019-2033
• Figure 143. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Oral, 2019-2033
• Figure 144. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Route of Administration 4, 2019-2033
• Figure 145. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Route of Administration 5, 2019-2033
• Figure 146. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Route of Administration 6, 2019-2033
• Figure 147. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Route of Administration 7, 2019-2033
• Figure 148. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Route of Administration 8, 2019-2033
• Figure 149. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Route of Administration 9, 2019-2033
• Figure 150. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Intravenous0, 2019-2033
• Figure 151. Asia Pacific Hereditary Angioedema Market Analysis, By Distribution Channel, 2019, 2023 and 2033
• Figure 152. Asia Pacific Hereditary Angioedema Market Attractiveness Analysis, By Distribution Channel
• Figure 153. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Hospital Pharmacies, 2019-2033
• Figure 154. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Retail Pharmacies, 2019-2033
• Figure 155. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Online Pharmacies, 2019-2033
• Figure 156. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Distribution Channel 4, 2019-2033
• Figure 157. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Distribution Channel 5, 2019-2033
• Figure 158. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Distribution Channel 6, 2019-2033
• Figure 159. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Distribution Channel 7, 2019-2033
• Figure 160. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Distribution Channel 8, 2019-2033
• Figure 161. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Distribution Channel 9, 2019-2033
• Figure 162. Asia Pacific Hereditary Angioedema Market (US$ Mn), by Hospital Pharmacies0, 2019-2033
• Figure 163. Asia Pacific Hereditary Angioedema Market Analysis, By Country, 2019, 2023 and 2033
• Figure 164. Asia Pacific Hereditary Angioedema Market Attractiveness Analysis, By Country
• Figure 165. Latin America Hereditary Angioedema Market Analysis, By Drug Class, 2019, 2023 and 2033
• Figure 166. Latin America Hereditary Angioedema Market Attractiveness Analysis, By Drug Class
• Figure 167. Latin America Hereditary Angioedema Market (US$ Mn), by C-1 Esterase Inhibitors, 2019-2033
• Figure 168. Latin America Hereditary Angioedema Market (US$ Mn), by Bradykynin Receptor Antagonist, 2019-2033
• Figure 169. Latin America Hereditary Angioedema Market (US$ Mn), by Kallikrein Inhibitors, 2019-2033
• Figure 170. Latin America Hereditary Angioedema Market (US$ Mn), by Others, 2019-2033
• Figure 171. Latin America Hereditary Angioedema Market (US$ Mn), by Drug Class 5, 2019-2033
• Figure 172. Latin America Hereditary Angioedema Market (US$ Mn), by Drug Class 6, 2019-2033
• Figure 173. Latin America Hereditary Angioedema Market (US$ Mn), by Drug Class 7, 2019-2033
• Figure 174. Latin America Hereditary Angioedema Market (US$ Mn), by Drug Class 8, 2019-2033
• Figure 175. Latin America Hereditary Angioedema Market (US$ Mn), by Drug Class 9, 2019-2033
• Figure 176. Latin America Hereditary Angioedema Market (US$ Mn), by C-1 Esterase Inhibitors0, 2019-2033
• Figure 177. Latin America Hereditary Angioedema Market Analysis, By Treatment Approach, 2019, 2023 and 2033
• Figure 178. Latin America Hereditary Angioedema Market Attractiveness Analysis, By Treatment Approach
• Figure 179. Latin America Hereditary Angioedema Market (US$ Mn), by Acute Treatment, 2019-2033
• Figure 180. Latin America Hereditary Angioedema Market (US$ Mn), by Prophylactic (Preventive) Treatment, 2019-2033
• Figure 181. Latin America Hereditary Angioedema Market (US$ Mn), by On-demand (Symptom Relief) Treatment, 2019-2033
• Figure 182. Latin America Hereditary Angioedema Market (US$ Mn), by Treatment Approach 4, 2019-2033
• Figure 183. Latin America Hereditary Angioedema Market (US$ Mn), by Treatment Approach 5, 2019-2033
• Figure 184. Latin America Hereditary Angioedema Market (US$ Mn), by Treatment Approach 6, 2019-2033
• Figure 185. Latin America Hereditary Angioedema Market (US$ Mn), by Treatment Approach 7, 2019-2033
• Figure 186. Latin America Hereditary Angioedema Market (US$ Mn), by Treatment Approach 8, 2019-2033
• Figure 187. Latin America Hereditary Angioedema Market (US$ Mn), by Treatment Approach 9, 2019-2033
• Figure 188. Latin America Hereditary Angioedema Market (US$ Mn), by Acute Treatment0, 2019-2033
• Figure 189. Latin America Hereditary Angioedema Market Analysis, By Route of Administration, 2019, 2023 and 2033
• Figure 190. Latin America Hereditary Angioedema Market Attractiveness Analysis, By Route of Administration
• Figure 191. Latin America Hereditary Angioedema Market (US$ Mn), by Intravenous, 2019-2033
• Figure 192. Latin America Hereditary Angioedema Market (US$ Mn), by Subcutaneous, 2019-2033
• Figure 193. Latin America Hereditary Angioedema Market (US$ Mn), by Oral, 2019-2033
• Figure 194. Latin America Hereditary Angioedema Market (US$ Mn), by Route of Administration 4, 2019-2033
• Figure 195. Latin America Hereditary Angioedema Market (US$ Mn), by Route of Administration 5, 2019-2033
• Figure 196. Latin America Hereditary Angioedema Market (US$ Mn), by Route of Administration 6, 2019-2033
• Figure 197. Latin America Hereditary Angioedema Market (US$ Mn), by Route of Administration 7, 2019-2033
• Figure 198. Latin America Hereditary Angioedema Market (US$ Mn), by Route of Administration 8, 2019-2033
• Figure 199. Latin America Hereditary Angioedema Market (US$ Mn), by Route of Administration 9, 2019-2033
• Figure 200. Latin America Hereditary Angioedema Market (US$ Mn), by Intravenous0, 2019-2033
• Figure 201. Latin America Hereditary Angioedema Market Analysis, By Distribution Channel, 2019, 2023 and 2033
• Figure 202. Latin America Hereditary Angioedema Market Attractiveness Analysis, By Distribution Channel
• Figure 203. Latin America Hereditary Angioedema Market (US$ Mn), by Hospital Pharmacies, 2019-2033
• Figure 204. Latin America Hereditary Angioedema Market (US$ Mn), by Retail Pharmacies, 2019-2033
• Figure 205. Latin America Hereditary Angioedema Market (US$ Mn), by Online Pharmacies, 2019-2033
• Figure 206. Latin America Hereditary Angioedema Market (US$ Mn), by Distribution Channel 4, 2019-2033
• Figure 207. Latin America Hereditary Angioedema Market (US$ Mn), by Distribution Channel 5, 2019-2033
• Figure 208. Latin America Hereditary Angioedema Market (US$ Mn), by Distribution Channel 6, 2019-2033
• Figure 209. Latin America Hereditary Angioedema Market (US$ Mn), by Distribution Channel 7, 2019-2033
• Figure 210. Latin America Hereditary Angioedema Market (US$ Mn), by Distribution Channel 8, 2019-2033
• Figure 211. Latin America Hereditary Angioedema Market (US$ Mn), by Distribution Channel 9, 2019-2033
• Figure 212. Latin America Hereditary Angioedema Market (US$ Mn), by Hospital Pharmacies0, 2019-2033
• Figure 213. Latin America Hereditary Angioedema Market Analysis, By Country, 2019, 2023 and 2033
• Figure 214. Latin America Hereditary Angioedema Market Attractiveness Analysis, By Country
• Figure 215. Middle East & Africa Hereditary Angioedema Market Analysis, By Drug Class, 2019, 2023 and 2033
• Figure 216. Middle East & Africa Hereditary Angioedema Market Attractiveness Analysis, By Drug Class
• Figure 217. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by C-1 Esterase Inhibitors, 2019-2033
• Figure 218. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Bradykynin Receptor Antagonist, 2019-2033
• Figure 219. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Kallikrein Inhibitors, 2019-2033
• Figure 220. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Others, 2019-2033
• Figure 221. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Drug Class 5, 2019-2033
• Figure 222. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Drug Class 6, 2019-2033
• Figure 223. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Drug Class 7, 2019-2033
• Figure 224. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Drug Class 8, 2019-2033
• Figure 225. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Drug Class 9, 2019-2033
• Figure 226. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by C-1 Esterase Inhibitors0, 2019-2033
• Figure 227. Middle East & Africa Hereditary Angioedema Market Analysis, By Treatment Approach, 2019, 2023 and 2033
• Figure 228. Middle East & Africa Hereditary Angioedema Market Attractiveness Analysis, By Treatment Approach
• Figure 229. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Acute Treatment, 2019-2033
• Figure 230. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Prophylactic (Preventive) Treatment, 2019-2033
• Figure 231. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by On-demand (Symptom Relief) Treatment, 2019-2033
• Figure 232. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Treatment Approach 4, 2019-2033
• Figure 233. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Treatment Approach 5, 2019-2033
• Figure 234. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Treatment Approach 6, 2019-2033
• Figure 235. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Treatment Approach 7, 2019-2033
• Figure 236. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Treatment Approach 8, 2019-2033
• Figure 237. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Treatment Approach 9, 2019-2033
• Figure 238. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Acute Treatment0, 2019-2033
• Figure 239. Middle East & Africa Hereditary Angioedema Market Analysis, By Route of Administration, 2019, 2023 and 2033
• Figure 240. Middle East & Africa Hereditary Angioedema Market Attractiveness Analysis, By Route of Administration
• Figure 241. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Intravenous, 2019-2033
• Figure 242. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Subcutaneous, 2019-2033
• Figure 243. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Oral, 2019-2033
• Figure 244. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Route of Administration 4, 2019-2033
• Figure 245. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Route of Administration 5, 2019-2033
• Figure 246. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Route of Administration 6, 2019-2033
• Figure 247. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Route of Administration 7, 2019-2033
• Figure 248. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Route of Administration 8, 2019-2033
• Figure 249. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Route of Administration 9, 2019-2033
• Figure 250. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Intravenous0, 2019-2033
• Figure 251. Middle East & Africa Hereditary Angioedema Market Analysis, By Distribution Channel, 2019, 2023 and 2033
• Figure 252. Middle East & Africa Hereditary Angioedema Market Attractiveness Analysis, By Distribution Channel
• Figure 253. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Hospital Pharmacies, 2019-2033
• Figure 254. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Retail Pharmacies, 2019-2033
• Figure 255. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Online Pharmacies, 2019-2033
• Figure 256. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Distribution Channel 4, 2019-2033
• Figure 257. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Distribution Channel 5, 2019-2033
• Figure 258. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Distribution Channel 6, 2019-2033
• Figure 259. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Distribution Channel 7, 2019-2033
• Figure 260. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Distribution Channel 8, 2019-2033
• Figure 261. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Distribution Channel 9, 2019-2033
• Figure 262. Middle East & Africa Hereditary Angioedema Market (US$ Mn), by Hospital Pharmacies0, 2019-2033
• Figure 263. Middle East & Africa Hereditary Angioedema Market Analysis, By Country, 2019, 2023 and 2033
• Figure 264. Middle East & Africa Hereditary Angioedema Market Attractiveness Analysis, By Country